DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Neurovascular Stents 2017 - MedCore" report to their offering.
High single digit market growth will be seen throughout the forecast period for neurovascular stents as next generation devices continue to enter the U.S. market. Traditional coil assisted stenting will continue to grow in unit sales while flow diversion stenting, a new and promising endovascular treatment, will experience rapid growth as well.
Sales of these devices in the U.S. only began in 2011 following the approval of the Pipeline device from Medtronic. Flow diversion stents have the potential to cannibalize a portion of traditional stent sales but they will both continue to experience growth.
These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations. The high market value is in part attributable to the fact that flow diversion stents command an ASP of nearly twice that of a traditional stent. Both types of stents are expected to experience marginal increases in pricing due to innovation, which will also drive market growth.
Key Topics Covered:
Table Of Contents I
List Of Figures Ix
List Of Charts Xi
U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview
Procedure Codes Investigated
Key Report Updates
St. Jude Medical
Codman & Shurtleff
For more information about this report visit http://www.researchandmarkets.com/research/fd29hc/us_market_report